BMS-P5
BMS-P5 is a selective and orally active peptidylarginine deiminase 4 (PAD4) inhibitor with an IC50 of 98 nM. BMS-P5 shows selective for PAD4 over PAD1, PAD2, and PAD3. BMS-P5 blocks multiple myeloma (MM) -induced neutrophil extracellular trap (NET) formation and delays progression of MM in a syngeneic mouse model[1].
Product Specifications
CAS Number
1549811-36-0
UNSPSC
12352005
Target
Protein Arginine Deiminase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bms-p5.html
Purity
99.23
Solubility
DMSO : 35 mg/mL (ultrasonic)
Smiles
O=C(N1[C@@H](C)CC[C@@H](N)C1)C2=CC(OC)=C3C(N=C(C4=CC5=CC=CN=C5N4CC6CC6)N3C)=C2.[H]Cl
Molecular Formula
C27H33ClN6O2
Molecular Weight
509.04
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SLC25A6 (Solute Carrier Family 25 (Mitochondrial Carrier; adenine Nucleotide Translocator), Member 6, AAC3, ANT3, ANT3Y, MGC17525) (APC)
INHBE Polyclonal Antibody, APC-Cy5.5 Conjugated